HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rui Henrique Selected Research

R-cadherin

2/2022Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rui Henrique Research Topics

Disease

121Neoplasms (Cancer)
11/2022 - 10/2003
53Prostatic Neoplasms (Prostate Cancer)
06/2022 - 11/2004
30Carcinogenesis
02/2022 - 01/2006
21Carcinoma (Carcinomatosis)
11/2018 - 05/2002
19Renal Cell Carcinoma (Grawitz Tumor)
02/2022 - 04/2007
16Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
08/2021 - 02/2005
16Breast Neoplasms (Breast Cancer)
06/2021 - 02/2004
13Urinary Bladder Neoplasms (Bladder Cancer)
02/2022 - 12/2010
8Neoplasm Metastasis (Metastasis)
06/2020 - 01/2017
7Colorectal Neoplasms (Colorectal Cancer)
11/2018 - 08/2011
5Urologic Neoplasms (Urological Cancer)
03/2021 - 12/2007
4Lung Neoplasms (Lung Cancer)
06/2022 - 12/2013
4Testicular Germ Cell Tumor
01/2021 - 01/2020
4Adenocarcinoma
09/2020 - 12/2002
4Prostatic Intraepithelial Neoplasia
01/2019 - 12/2004
4Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
01/2019 - 08/2015
3Kidney Neoplasms (Kidney Cancer)
12/2021 - 01/2011
3Disease Progression
03/2021 - 10/2019
3Inflammation (Inflammations)
10/2020 - 10/2003
3Oxyphilic Adenoma (Oncocytoma)
01/2015 - 07/2007
3Squamous Cell Carcinoma of Head and Neck
07/2011 - 10/2006
2Fibroadenoma
01/2022 - 05/2008
2Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2021 - 12/2019
2Seminoma
08/2021 - 12/2019
2Circulating Neoplastic Cells
04/2021 - 03/2021
2Hypoxia (Hypoxemia)
12/2020 - 11/2019
2Metaplasia
09/2020 - 09/2011
2Necrosis
08/2020 - 04/2012
2Abdominal Obesity
09/2019 - 08/2018
2Proteinuria
01/2019 - 10/2007
2Microsatellite Instability
12/2017 - 10/2010
2Genetic Predisposition to Disease (Genetic Predisposition)
11/2014 - 09/2010
2Hyperplasia
08/2010 - 11/2006
1Lymphoma (Lymphomas)
07/2022

Drug/Important Bio-Agent (IBA)

75Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2007
27Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2005
27DNA (Deoxyribonucleic Acid)IBA
01/2021 - 12/2002
23Biological ProductsIBA
02/2022 - 01/2011
21MicroRNAs (MicroRNA)IBA
02/2022 - 10/2011
14Histones (Histone)IBA
12/2021 - 02/2005
13Messenger RNA (mRNA)IBA
02/2022 - 11/2006
12EnzymesIBA
12/2021 - 05/2002
11MethyltransferasesIBA
06/2022 - 05/2011
9RNA (Ribonucleic Acid)IBA
11/2022 - 06/2009
8Cell-Free Nucleic AcidsIBA
06/2022 - 09/2018
8Tumor Biomarkers (Tumor Markers)IBA
01/2022 - 01/2007
6ChromatinIBA
01/2022 - 02/2005
6Cisplatin (Platino)FDA LinkGeneric
08/2021 - 01/2017
6Phenobarbital (Luminal)FDA Link
12/2020 - 04/2016
5Proto-Oncogene Proteins c-etsIBA
07/2013 - 01/2012
4Cadherins (E-Cadherin)IBA
02/2022 - 09/2005
4Protein Isoforms (Isoforms)IBA
01/2022 - 05/2005
4Androgen Receptors (Androgen Receptor)IBA
01/2022 - 10/2011
4N-methyladenosineIBA
01/2022 - 03/2020
46-methyladenineIBA
09/2021 - 12/2019
4A-Form DNA (A-DNA)IBA
08/2021 - 11/2018
4DecitabineFDA Link
01/2020 - 10/2006
4Histone MethyltransferasesIBA
01/2017 - 01/2015
4hydrogen sulfite (bisulfite)IBA
05/2014 - 03/2008
3Hydralazine (Apresoline)FDA LinkGeneric
08/2021 - 08/2014
3Prostate-Specific Antigen (Semenogelase)IBA
07/2020 - 10/2007
3ParaffinIBA
04/2020 - 07/2007
3NucleosidesIBA
01/2020 - 01/2014
3Glucose (Dextrose)FDA LinkGeneric
09/2019 - 01/2017
3Transcription Factors (Transcription Factor)IBA
11/2018 - 01/2011
3Transforming Growth Factor-beta Type II ReceptorIBA
08/2015 - 10/2010
2PlatinumIBA
06/2022 - 01/2020
2ProteomeIBA
12/2021 - 01/2021
2flavanoneIBA
09/2021 - 01/2021
2PanobinostatIBA
07/2021 - 10/2020
2TamoxifenFDA LinkGeneric
06/2021 - 11/2018
2Telomerase (Telomerase Reverse Transcriptase)IBA
11/2020 - 06/2019
2Histone Deacetylase InhibitorsIBA
10/2020 - 05/2011
2SirtuinsIBA
04/2020 - 01/2020
2Formaldehyde (Formol)FDA Link
04/2020 - 11/2019
2Histone Deacetylases (Histone Deacetylase)IBA
01/2020 - 07/2015
2Sirtuin 1IBA
01/2020 - 10/2013
2AntibodiesIBA
11/2019 - 09/2011
2Nonsense Codon (Nonsense Mutation)IBA
01/2019 - 02/2016
2Volatile Organic CompoundsIBA
01/2018 - 01/2017
2Calcibiotic Root Canal SealerIBA
12/2017 - 08/2015
2Histone DemethylasesIBA
01/2017 - 01/2015
2ErbB Receptors (EGF Receptor)IBA
09/2016 - 08/2011
2Cysteine (L-Cysteine)FDA Link
08/2016 - 01/2011
2Cyclin D2IBA
05/2015 - 11/2006
2CateninsIBA
05/2015 - 01/2015
2trichostatin A (A 300)IBA
10/2013 - 05/2011
2Toll-Like Receptors (Toll-Like Receptor)IBA
02/2013 - 04/2012
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2012 - 07/2007
2Carrier Proteins (Binding Protein)IBA
05/2011 - 06/2008
2Genetic Markers (Genetic Marker)IBA
06/2008 - 03/2008
2Tumor Suppressor Protein p14ARF (p14ARF)IBA
09/2005 - 12/2004
1GuanineIBA
11/2022
1CytosineIBA
11/2022
1Phosphates (Orthophosphate)IBA
11/2022

Therapy/Procedure

33Therapeutics
07/2022 - 02/2004
6Drug Therapy (Chemotherapy)
06/2022 - 09/2010
4Radiotherapy
12/2020 - 01/2017
3Prostatectomy (Retropubic Prostatectomy)
10/2020 - 01/2006
2Lasers (Laser)
01/2017 - 01/2006